Pharmacogenetic

Outcomes among children with acute myeloid leukemia treated with high-dose cytarabine-based regimens did not vary by race, according to study results presented at ASH Annual Meeting and Exposition.

Targeted pharmacogenetic-guided treatment may improve outcomes in patients with depression, according to a study presented at the American Psychiatric Association Annual Meeting.

A combinatorial pharmacogenomic test significantly improved outcomes among patients with major depressive disorder who had at least one prior medication failure, according to results of a randomized controlled trial published in The Journal of Clinical Psychiatry.